We tested whether the MOR partial agonist buprenorphine was able to effectively prevent respiratory depression induced by the MOR full agonist fentanyl in opioid-naive volunteers and in individuals with chronic opioid use. The gene discussed is OPRM1; the disease is respiratory depression.